PI3Kα targeting, nipping pancreatic cancer evolution in the bud

Glancis Luzeena Raja Arul; Martin E Fernandez‐Zapico

doi:10.15252/emmm.202114362

EMBO Molecular Medicine (May 2021)

PI3Kα targeting, nipping pancreatic cancer evolution in the bud

Glancis Luzeena Raja Arul,
Martin E Fernandez‐Zapico

Affiliations

Glancis Luzeena Raja Arul: Schulze Center for Novel Therapeutics, Mayo Clinic
Martin E Fernandez‐Zapico: Schulze Center for Novel Therapeutics, Mayo Clinic

DOI: https://doi.org/10.15252/emmm.202114362
Journal volume & issue: Vol. 13, no. 7
pp. 1 – 3

Abstract

Read online

Abstract Thibault et al (2021) elucidate key signalling events mediating metastatic evolution in pancreatic ductal adenocarcinoma (PDAC) by demonstrating a role of PI3Kα in the regulation of macro‐metastatic disease and a corresponding pro‐tumoural immune response supporting disease progression.

Published in EMBO Molecular Medicine

ISSN: 1757-4676 (Print); 1757-4684 (Online)
Publisher: Springer Nature
Country of publisher: United Kingdom
LCC subjects: Medicine: Medicine (General); Science: Biology (General): Genetics
Website: https://www.embopress.org/journal/17574684

About the journal